Antimicrobial resistance: addressing the risks

Public Accounts Committee Closed Inquiry
Opened: 15 Jan 2025 Closed: 21 Aug 2025 Parliament page
Antimicrobial-resistant (AMR) infections cause an estimated 1.3m deaths globally each year, and rising, and lead to the failure of antibiotics for treating human illness. 67,000 people experienced an AMR infection in 2023. 2,200 of those people died. The UN has predicted that by 2050, AMR will cause 10m or more … Read more
18 Recommendations
28 Conclusions
1 Report
1 Oral session
1 Event
Activity timeline 4 events
27 Mar
2025
27 Mar
2025
Formal meeting (oral evidence session) · The Thatcher Room, Portcullis House
Oral evidence sessions 1 session
Abigail Seager · Defra Dr David Partridge · Sheffield Teaching Hospitals NHS Trust Professor Sir Chris Whitty · Department for Health and Social Care Professor Sir Stephen Powis · NHS England Professor Susan Hopkins · UK Health Security Agency (UKHSA) The Lord O'Neill of Gatley
Recommendations & Conclusions
1 result
13 Recommendation Accepted in Part
30th Report - Antimicrobial resist…
New 2024-29 AMR Action Plan targets are less ambitious and potentially insufficient
The 2024–29 National Action Plan (NAP) includes new targets which are less stretching than the targets in the 2019–24 NAP. While the government previously set targets for reductions of 50% in Gram-negative bloodstream infections and 10% in drug-resistant infections, the … Read more
Government Response
The government agrees to monitor progress against NAP human health targets biannually and review them annually, with potential for revision if deemed appropriate, but states that preventing an increase in drug-resistant and gram-negative bloodstream infections from the 2019 baseline is already ambitious due to demographic changes.
HM Treasury
View details
Government Response AI assessment · 46 of 18 classified

Total 18 recs + 28 conclusions